Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
INDUSTRY
×
etoposide phosphate
×
1 year
×
Clear all
Filters
3
NCT04663347
2026-03-03
EPCOREâ„¢ NHL-2
Genmab
Phase 1/2
Active not recruiting
543 enrolled
NCT03407144
2026-02-19
MK-3475-667
Merck Sharp & Dohme LLC
Phase 2
Active not recruiting
340 enrolled
NCT06230224
2026-02-06
OLYMPIA-4
Regeneron Pharmaceuticals
Phase 3
Recruiting
216 enrolled
NCT02964013
2025-10-14
KEYVIBE-001
Merck Sharp & Dohme LLC
Phase 1
Completed
474 enrolled
39 charts
NCT04924101
2025-07-23
KEYNOTE-B99
Merck Sharp & Dohme LLC
Phase 2
Completed
126 enrolled